Status:
COMPLETED
Anterior Segment Changes After Pars Plana Vitrectomy With SO Using AS-OCT
Lead Sponsor:
Minia University
Conditions:
Glaucoma
Eligibility:
All Genders
16-75 years
Brief Summary
To evaluate changes in ACA induced by pars plana vitrectomy with SO 1000cs injection in vitreo-retinal surgery in phakic eyes using AS-OCT and changes in the IOP preoperatively, post-operatively and p...
Detailed Description
Abstract Introduction Ocular hypertension and secondary glaucoma are relatively common and serious complications in silicone filled eyes which may end in blindness. Reports have described the percenta...
Eligibility Criteria
Inclusion
- • Patients with rhegmatogenous retinal detachment who are going to undergo vitreoretinal surgery with silicone oil 1000cs injection as tamponade
Exclusion
- Patients with history of intraocular surgery, laser therapy or intravitreal injection.
- Patients with significant corneal opacity.
- Patients with ocular diseases as retinal vein occlusion, uveitis and proliferative diabetic retinopathy.
- Patients with preexisting glaucoma or family history of glaucoma.
- Patients with nystagmus.
- Patient with tractional retinal detachment, exudative retinal detachment or intraocular foreign body.
- Patients with anterior chamber abnormalities including posterior synechia, peripheral anterior synechia, hyphaema and iris abnormalities.
- Patients with severe proliferative vitreoretinopathy grade C or more.
Key Trial Info
Start Date :
April 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06524661
Start Date
April 15 2023
End Date
April 15 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine ,Minia university
Minya, Egypt, 61519